Literature DB >> 9222491

Renal osteodystrophy.

K A Hruska1.   

Abstract

Renal osteodystrophy is a general complication of chronic renal failure and end-stage renal disease. The nature of renal osteodystrophy has changed since osteomalacia due to aluminum intoxication has become less prevalent. Osteomalacia has been replaced by the adynamic bone disorder. Suppression of osteitis fibrosa, calcitrol and control of secondary hyperparathyroidism has been shown to produce the adynamic bone disorder. Thus, many other factors besides secondary hyperparathyroidism and calcitrol deficiency contribute to the pathogenesis of renal osteodystrophy. Some of these factors, according to our current state of knowledge, are discussed in this chapter along with the presentation and treatment of renal osteodystrophy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9222491     DOI: 10.1016/s0950-351x(97)80585-x

Source DB:  PubMed          Journal:  Baillieres Clin Endocrinol Metab        ISSN: 0950-351X


  3 in total

1.  Biochemical indices of renal osteodystrophy in dialysis patients on the island of Malta.

Authors:  Ian Galea; Emanuel Farrugia
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 2.  Sickle cell disease as an accelerated aging syndrome.

Authors:  Ibrahim M Idris; Edward A Botchwey; Hyacinth I Hyacinth
Journal:  Exp Biol Med (Maywood)       Date:  2022-02-16

3.  1α,24(S)(OH)2D2 normalizes bone morphology and serum parathyroid hormone without hypercalcemia in 25-hydroxyvitamin D-1-hydroxylase (CYP27B1)-deficient mice, an animal model of vitamin D deficiency with secondary hyperparathyroidism.

Authors:  R St-Arnaud; A Arabian; V W C Yu; O Akhouayri; J C Knutson; S A Strugnell
Journal:  J Endocrinol Invest       Date:  2008-08       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.